Article and Video CATEGORIES

Cancer Journey

Search By

Clinical Care Options 2018 - Measurable Residual Disease in Acute Lymphoblastic Leukemia
Mon, 12/17/2018 - 18:10
CCO 2018 - MRD in ALL
Author
GRACE Videos and Articles
Image

GRACE has partnered with Clinical Care Options (CCO) Oncology, to share with our community a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).


We are thrilled to share with you video discussions with the following panel:

  • ~Elias Jabbour, MD, Associate Professor Department of Leukemia at the University of Texas MD Anderson Cancer Center in Houston, Texas
  • ~Joseph D. Khoury, MD, Professor, Department of Hematology at the University of Texas MD Anderson Cancer Center in Houston, Texas 
  • ~Aaron C. Logan, MD, Ph.D., Associate Professor Division of Hematology and Blood and Marrow Transplantation at the University of California, San Francisco

In this video series, the doctors discuss MRD in ALL.  Topics include:

Measurable Residual Disease - What Can Physicians Do with MRD Information

Measurable Residual Disease - What Does it Mean to be MRD Positive

Measurable Residual Disease - What is MRD and Why is it Important

Measurable Residual Disease - What Tests Used, How do They Work, and Which is Best for the Patient

Measurable Residual Disease - When Should they Test MRD and How do they get MRD from Patients


For more information about this video program with CCO - please visit https://www.clinicaloptions.com/oncology/programs/mrd-in-all/on-demand-….

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Spanish Targeted Therapy Lung Cancer Patient Forum 2023
Video
2023 Terapias Dirigidas en el Foro de Pacientes con Cáncer de Pulmón El vídeo completo sin editar está disponible On Demand   View HERE  
Image
Spanish TTF 2023
Article
Únete a nosotros, sábado 12 de agosto a las 9:00 a.m.  En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras.  
Image
Targeted Therapies in Lung Cancer Patient Forum 2023
Article
Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.  

Forum Discussions

Hi, I'm sorry you're having these issues.  The type of shoulder pain that feels like nerve pain is most likely nerve pain.  The type of tumor that causes similar shoulder pain...

Thank you so much for the response! I have seen a lot of your post on here and it's really awesome of you to take the time to reply to all...

ONKTALK is tomorrow. 

I hope to see you there.

The forum is now available on demand here.  Don't hesitate to ask questions as they come up. 

Take care,

Janine

Hi happybluesun,  Welcome to Grace.   I'm sorry your mom is going through this. 

 

Driver mutations are mutations that drive (or cause) the cancer.  Having more than one driver mutation is...

Hi Janine, thank you very much for your reply. As of June 2023, my mom has been prescribed Almonertibi Mesilate Tablet, a targeted therapy medicine made by the Chinese company Haosen...

Recent Comments

JOIN THE CONVERSATION
Thank you so much for the…
By Worried472 on Tue, 09/26/2023 - 12:44
Hi, I'm sorry you're having…
By JanineT GRACE … on Tue, 09/26/2023 - 11:24
The forum is now available…
By JanineT GRACE … on Mon, 09/25/2023 - 14:10
Reminder
By JanineT GRACE … on Fri, 09/22/2023 - 15:50